Related Experiment Video
Updated: Aug 23, 2025
05:14
Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
3.7K
Proline Metabolism in Neurological and Psychiatric Disorders
1The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou 510180, China.
Molecules and Cells
|November 3, 2022
Summary
Proline metabolism is crucial for neuronal function and brain health. Dysregulation of this amino acid pathway is linked to neurological and psychiatric disorders, suggesting potential therapeutic targets.
Area of Science:
- Neuroscience
- Biochemistry
- Metabolic pathways
Background:
- Proline is a vital amino acid involved in protein synthesis, redox balance, and cell fate.
- Its metabolism is essential for normal brain development and function.
- Aberrant proline metabolism is increasingly implicated in various neurological conditions.
Purpose of the Study:
- To review the role of proline metabolism in neuronal function.
- To highlight the link between dysregulated proline metabolism and neurological/psychiatric disorders.
- To explore potential therapeutic strategies targeting proline pathways.
Main Methods:
- Literature review of proline metabolism in neurons.
- Analysis of genetic and enzymatic factors in proline pathways.
- Correlation of proline metabolism with neurological disease mechanisms.
Main Results:
- Proline metabolism significantly impacts neuronal health and function.
- Genetic variations and altered enzyme activity in the proline pathway are associated with neurological and psychiatric disorders.
- Dysregulation contributes to neuronal dysfunction.
Conclusions:
- Proline metabolism is a critical determinant of neuronal health.
- Targeting proline metabolic pathways may offer novel therapeutic avenues for neurological and psychiatric diseases.
- Further research into proline's role in mental health is warranted.
Related Concept Videos
01:23Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
278
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
278
01:24Parkinson's Disease: Treatment
352
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
352
01:29Drugs Affecting Neurotransmitter Synthesis
1.5K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.5K
01:15Parkinson's Disease: Overview
671
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
671
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
883
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
883
01:28Disorders of the Nervous Tissue
1.5K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.5K